Researchers define shape of enzyme linked to prostate, breast cancers
(Medical Xpress) -- A University of Kansas researcher has made a discovery that should lead to improved treatments for prostate and breast cancer.
Jan 25, 2012
0
0
(Medical Xpress) -- A University of Kansas researcher has made a discovery that should lead to improved treatments for prostate and breast cancer.
Jan 25, 2012
0
0
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number ...
Jan 23, 2012
0
0
High street coffee chains are unwittingly putting pregnant women at risk due to huge variations in their caffeine content.
Dec 2, 2011
0
0
(AP) -- Count your blessings this Thanksgiving. It's good for you.
Nov 22, 2011
0
0
(Medical Xpress) -- Novacta Biosystems has commenced dosing of the first healthy volunteers in a phase I clinical trial of a new antibiotic to treat the hospital superbug Clostridium difficile.
Nov 9, 2011
0
0
(Medical Xpress) -- Amphetamine use in adolescence can cause neurobiological imbalances and increase risk-taking behaviour, and these effects can persist into adulthood, even when subjects are drug free. These are the conclusions ...
Nov 3, 2011
0
0
A research team led by investigators at the Virginia Tech Carilion Research Institute has demonstrated the first rapid measurements of dopamine release in a human brain and provided preliminary evidence that the neurotransmitter ...
Oct 28, 2011
8
0
Toxoplasma gondii parasites can invade your bloodstream, break into your brain and prompt behavioral changes from recklessness to neuroticism. These highly contagious protozoa infect more than half the world's population, ...
Sep 20, 2011
2
2
A University of Illinois study reports a promising new weapon in treating metastatic colon cancer, particularly in patients who have developed resistance to chemotherapy.
Sep 19, 2011
0
0
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.
Sep 4, 2011
0
0